List of insiders holdings for MADRIGAL PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| CxSynta LLC CAXTON CORP 10% Owner | 2015-11-20 19:00:14 | 28,991,306 0 | 28,991,306 | Form 13D |
| Kovner Bruce Director 10% Owner | 2015-12-08 14:09:10 | 3,092,677 18,019,580 | 21,112,257 | Form 4 |
| Chen Lin Huey 10% Owner | 2010-02-12 18:21:53 | 0 2,570,947 | 2,570,947 | Form 5/A |
| Bahcall Safi R President and CEO | 2014-02-13 16:25:26 | 1,853,135 580,000 | 2,433,135 | Form 5 |
| Chen Lan Bo Director | 2013-02-14 06:03:03 | 2,387,284 0 | 2,387,284 | Form 13G |
| BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 2024-03-25 16:28:21 | 2,070,544 0 | 2,070,544 | Form 13D |
| BAKER BROS. ADVISORS LP Director | 2024-03-25 16:28:21 | 2,070,544 0 | 2,070,544 | Form 13D |
| CRAVES FRED B Director | 2023-12-11 19:25:26 | 413,362 1,631,656 | 2,045,018 | Form 4 |
| Taub Rebecca Pres., R&D, and CMO | 2024-04-10 20:53:46 | 535,563 655,540 | 1,191,103 | Form 4 |
| FRIEDMAN PAUL A Director | 2024-04-10 20:50:27 | 391,991 655,540 | 1,047,531 | Form 4 |
| WILSON ROBERT N Director | 2015-07-06 16:38:33 | 780,936 0 | 780,936 | Form 4 |
| BAY CITY CAPITAL LLC Bay City Capital Management IV LLC Bay City Capital Fund IV L.P. BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP 10% Owner | 2023-12-13 16:05:57 | 567,644 0 | 567,644 | Form 13D |
| Ramachandra Sumant President, R&D | 2013-03-13 17:53:37 | 300,000 0 | 300,000 | Form 4 |
| Bernitz Steven B SVP, Corporate Development | 2013-12-20 16:23:42 | 175,000 0 | 175,000 | Form 4 |
| Vukovic Vojo SVP, Chief Medical Officer | 2015-10-06 17:33:43 | 132,300 0 | 132,300 | Form 4 |
| McMahon Arthur SVP, Human Resources | 2015-03-04 17:15:49 | 126,768 0 | 126,768 | Form 4 |
| Whitaker Anne Clem President and CEO | 2015-03-04 17:00:57 | 100,000 0 | 100,000 | Form 4 |
| Chadwick Jeremy G Sr. VP, Pgm Mgmt and Clin Ops | 2010-03-03 16:50:15 | 97,186 0 | 97,186 | Form 4 |
| Sibold William John President and CEO | 2024-01-25 15:24:16 | 92,959 0 | 92,959 | Form 4 |
| REARDON WILLIAM S Director | 2015-07-06 16:34:50 | 69,392 0 | 69,392 | Form 4 |
| Ehrlich Keith S VP, Fin. and Admin., CFO | 2014-03-05 19:03:06 | 66,985 0 | 66,985 | Form 4 |
| Koya Keizo Sr. VP, Drug Development | 2012-03-08 20:20:33 | 63,036 0 | 63,036 | Form 4 |
| Jacobson Eric W Sr. VP, Research and CMO | 2009-04-14 16:51:45 | 47,112 0 | 47,112 | Form 4 |
| Barsoum James G Sr. VP, Research | 2009-04-14 16:46:10 | 42,900 0 | 42,900 | Form 4 |
| Williams Martin D Sr. VP, Business Dev., CBO | 2008-02-29 14:00:34 | 42,120 0 | 42,120 | Form 4 |
| Schor Chen Former President and CEO | 2016-07-22 17:23:27 | 37,178 0 | 37,178 | Form 4 |
| Schneebaum Marc R Chief Financial Officer | 2021-02-23 13:32:44 | 32,000 0 | 32,000 | Form 4 |
| Dier Mardi SVP and CFO | 2024-03-21 16:30:15 | 31,103 0 | 31,103 | Form 3 |
| Howarth Alex G. Chief Financial Officer | 2024-01-25 15:29:59 | 30,778 0 | 30,778 | Form 4 |
| BAILEY MICHAEL P Sr. VP, Chief Comm. Officer | 2010-08-06 16:41:58 | 29,627 0 | 29,627 | Form 4 |
| Lynch Brian Joseph SVP and General Counsel | 2024-01-25 15:24:30 | 26,813 530 | 27,343 | Form 4 |
| Levy Richard S Director | 2024-04-03 20:47:46 | 25,298 0 | 25,298 | Form 4 |
| BATE KENNETH Director | 2024-04-03 20:44:23 | 22,410 0 | 22,410 | Form 4 |
| Huntsman Carole Chief Commercial Officer | 2024-01-25 18:04:23 | 20,595 0 | 20,595 | Form 4 |
| KUFE DONALD W Director | 2015-07-06 16:32:21 | 20,000 0 | 20,000 | Form 4 |
| Morenstein Scott D Director | 2016-01-05 18:32:11 | 17,857 0 | 17,857 | Form 4 |
| Rieder Wendy E Former SVP, Gen. Counsel | 2016-07-22 17:18:07 | 17,730 0 | 17,730 | Form 4 |
| Singh Amar Sr. VP, Chief Business Officer | 2014-02-13 16:23:05 | 15,161 0 | 15,161 | Form 5 |
| Sukhija Remy Chief Commercial Officer | 2023-01-18 20:00:34 | 15,001 0 | 15,001 | Form 4 |
| Daly James M Director | 2024-04-03 20:41:46 | 12,110 0 | 12,110 | Form 4 |
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2024-01-25 17:50:59 | 10,093 0 | 10,093 | Form 4 |
| MILLIGAN DAVID V Director | 2022-06-21 06:30:25 | 9470 0 | 9470 | Form 4 |
| Gollust Keith R Director | 2022-06-21 06:30:09 | 9470 0 | 9470 | Form 4 |
| Folkman Judah Director | 2007-07-03 08:47:10 | 7676 0 | 7676 | Form 4 |
| Cheong Raymond Director | 2023-06-20 06:19:37 | 0 0 | 0 | Form 3 |